China Resources Double-Crane Pharmaceutical Co Ltd (600062) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People's Republic of China.

Total Assets Chart for China Resources Double-Crane Pharmaceutical Co Ltd

China Resources Double-Crane Pharmaceutical Co Ltd (600062) total assets for FY2025 were CNY 17.0B, a 1.9% change from FY2024. China Resources Double-Crane Pharmaceutical Co Ltd's total assets grew from CNY 131.3M in 1994 to CNY 17.0B in 2025 (12851.1% over 31 years). Total assets compound annual growth rate: 5-year CAGR of 6.5%, 10-year CAGR of 8.2%, 20-year CAGR of 7.8%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (CNY)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
¥16.75B
Implied Share Price
¥16.13
Enterprise Value
¥15.26B
Revenue (TTM)
¥10.73B
EBITDA
¥2.41B
Profit Margin
15.15%
Trailing P/E
10.34
Forward P/E
12.35
Price/Book (MRQ)
1.37
Price/Sales (TTM)
1.56
EV/EBITDA
5.78
EV/Revenue
1.41
Dividend Yield
0.00%
Book Value
¥11.26
Free Cash Flow (FY2025)
¥869.88M
Free Cash Flow Yield
5.19%

Snapshot as of 27th August 2026 — not point-in-time controlled, may lag the live market by a few days.